ES2097120T3 - Estabilizacion de proteinas altamente purificadas. - Google Patents

Estabilizacion de proteinas altamente purificadas.

Info

Publication number
ES2097120T3
ES2097120T3 ES90113210T ES90113210T ES2097120T3 ES 2097120 T3 ES2097120 T3 ES 2097120T3 ES 90113210 T ES90113210 T ES 90113210T ES 90113210 T ES90113210 T ES 90113210T ES 2097120 T3 ES2097120 T3 ES 2097120T3
Authority
ES
Spain
Prior art keywords
protein
stabilization
highly purified
purified proteins
carbohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90113210T
Other languages
English (en)
Inventor
Michael H Coan
Vivian W Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23517903&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2097120(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Application granted granted Critical
Publication of ES2097120T3 publication Critical patent/ES2097120T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN CARBOHIDRATO, TAL COMO MANITOL O DEXTRAN-70 SE AÑADE DURANTE LA PURIFICACION DE UNA PROTEINA, TAL COMO EL FACTOR VIII:C. EL CARBOHIDRATO ESTABILIZA LA PROTEINA, INCLUSO CUANDO LA PROTEINA SE ENCUENTRA ENTRE EL 60 Y 99% DE PUEREZA. EL CARBOHIDRATO SE AÑADE A TRAVES DE VARIOS PASOS DE PURIFICACION Y ESTA PRESENTE EN EL ENVASE FINAL PARA, DE ESTA FORMA, ESTABILIZAR LA PROTEINA DURANTE SU CONGELACION EN SECO Y SU RECONSTITUCION.
ES90113210T 1989-07-24 1990-07-11 Estabilizacion de proteinas altamente purificadas. Expired - Lifetime ES2097120T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38458489A 1989-07-24 1989-07-24

Publications (1)

Publication Number Publication Date
ES2097120T3 true ES2097120T3 (es) 1997-04-01

Family

ID=23517903

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90113210T Expired - Lifetime ES2097120T3 (es) 1989-07-24 1990-07-11 Estabilizacion de proteinas altamente purificadas.

Country Status (8)

Country Link
EP (1) EP0410207B1 (es)
JP (1) JPH0358998A (es)
AT (1) ATE148165T1 (es)
CA (1) CA2021452A1 (es)
DE (1) DE69029765T2 (es)
DK (1) DK0410207T3 (es)
ES (1) ES2097120T3 (es)
GR (1) GR3022614T3 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165467A (en) * 1991-07-20 2000-12-26 Yoshihide Hagiwara Stabilized human monoclonal antibody preparation
JP2966592B2 (ja) * 1991-07-20 1999-10-25 萩原 義秀 安定化されたヒトモノクローナル抗体製剤
US6270723B1 (en) * 1998-06-15 2001-08-07 Bbi Bioseq, Inc. Rapid cryobaric sterilization and vaccine preparation
CZ307715B6 (cs) 1999-02-22 2019-03-06 University Of Connecticut Způsob lyofilizace vodné farmaceutické formulace faktoru VIII prosté albuminu
DE60041363D1 (de) 1999-07-14 2009-02-26 Spectral Diagnostics Inc Präparierung von sphären für diagnostische tests
AU3070702A (en) 2000-11-07 2002-05-21 Chiron Corp Stabilized inteferon compositions
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
EP1417301B1 (en) * 2001-08-07 2006-11-02 Novozymes A/S Carbohydrates and polyols for dissolving protein crystals
KR20030060660A (ko) * 2002-01-10 2003-07-16 손정일 앞/뒷면 구별 없는 양면 양말
CA2492143A1 (en) * 2002-07-12 2004-01-22 Medarex, Inc. Methods and compositions for preventing oxidative degradation of proteins
WO2005103067A1 (en) * 2004-04-23 2005-11-03 Novexin Limited Methods and kits for stabilising, protecting and solubilising proteins
JP2008501639A (ja) * 2004-04-23 2008-01-24 ノベシン リミテッド タンパク質を安定化、保護及び可溶化させるための方法及びキット
CA2675602A1 (en) * 2007-02-16 2008-08-21 Wyeth Protein formulations containing sorbitol
JP2011520889A (ja) 2008-05-15 2011-07-21 バクスター・インターナショナル・インコーポレイテッド 安定な医薬製剤
TR201900207T4 (tr) 2008-11-07 2019-02-21 Baxalta GmbH Faktör VIII Formülasyonları
KR102023207B1 (ko) 2010-12-02 2019-11-25 온콜리틱스 바이오테크 인코포레이티드 동결건조 바이러스 제형
EA201390810A1 (ru) 2010-12-02 2013-09-30 Онколитикс Байотек Инк. Жидкие вирусные составы
KR102151890B1 (ko) * 2011-04-29 2020-09-03 온콜리틱스 바이오테크 인코포레이티드 겔 침투 크로마토그래피를 이용한 바이러스의 정제방법
ES2788870T3 (es) 2014-08-04 2020-10-23 Csl Ltd Formulación de factor VIII
KR20220029733A (ko) 2019-07-04 2022-03-08 체에스엘 베링 렝나우 아게 응고 인자 viii의 시험관내 안정성을 증가시키기 위한 절단된 폰 빌레브란트 인자 (vwf)
US20220380439A1 (en) 2020-11-09 2022-12-01 Takeda Pharmaceutical Company Limited Purification of fviii from plasma using silicon oxide adsorption

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
JPH0387173A (ja) * 1987-09-10 1991-04-11 Teijin Ltd ヒト活性化天然型ファクター８ｃの製造方法及びそれに用いる形質転換体
CA1329760C (en) * 1987-10-29 1994-05-24 Ted C. K. Lee Plasma and recombinant protein formulations in high ionic strength media

Also Published As

Publication number Publication date
GR3022614T3 (en) 1997-05-31
EP0410207A3 (en) 1992-01-15
ATE148165T1 (de) 1997-02-15
EP0410207B1 (en) 1997-01-22
JPH0358998A (ja) 1991-03-14
CA2021452A1 (en) 1991-01-25
DE69029765D1 (de) 1997-03-06
DE69029765T2 (de) 1997-05-15
EP0410207A2 (en) 1991-01-30
DK0410207T3 (da) 1997-07-14

Similar Documents

Publication Publication Date Title
ES2097120T3 (es) Estabilizacion de proteinas altamente purificadas.
DE3874798D1 (de) Therapeutisches proteinagens in form von aerosol.
DE68928956T2 (de) Verfahren zur Herstellung von optisch aktivem 1,3-Butanediol
DE69118535T2 (de) Osteo-induktive pharmazeutische formulierungen
CA2117193A1 (en) Vaccine comprising part of constant region of ige for treatment of ige-medicated allergic reactions
DE59308628D1 (de) Verfahren zur Herstellung von Faktor VIII
ATE95564T1 (de) Aeusseres membranprotein f von pseudomonas aeruginosa.
DE69219622T2 (de) Herstellung von optisch aktiven aliphatischen carbonsäuren
MC1884A1 (fr) Variants de l'hirudine,leur utilisation et leur preparation
ES2058479T3 (es) Compuestos peptidicos.
CA2105282A1 (en) Preparation of factor ix
DE69313099D1 (de) Herstellung von optisch aktiven aliphatischen carbonsäuren
NO942323D0 (no) Soyaprotein eller hydrolysater i farmasöytiske preparater for beskyttelse av bioaktive peptider mot enzymatisk inaktivering
DK0422846T3 (da) Aroylurinstoffer
DE69534738D1 (de) Leukocyten-aktivierender Faktor
DE59305709D1 (de) Verfahren zur Herstellung von 1,4-Diaminoanthrachinon-2,3-disulfonsäure und 1,4-Diaminoanthrachinon-2,3-dinitril
DE68915694T2 (de) Verfahren zur Herstellung von verzweigten 1,3-Glykolen und ihren Monoestern.
DE59307374D1 (de) Verfahren zur Herstellung von 5-Halogen-2-(1-anthrachinonylamino)benzoesäuren und 4'-Halogen-2,1(N)-anthrachinonyl-1',2'(N)-benzacridonen
TH31446EX (th) ขวด
TH23850EX (th) ขวด
TH40331EX (th) ลัง

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 410207

Country of ref document: ES